( 9266 results )

NCLAT: Cyrus Investments Pvt. Ltd. & Anr. vs. Tata Sons Ltd. & Ors

  • Citation Number : LSI-716-NCLAT-2019(NDEL)

NCLAT: Unsuccessful resolution applicant has no vested fundamental right to challenge CoC-approved plan

  • Citation Number : LSI-715-NCLAT-2019(NDEL)

SC: No condonation of delay for arbitration appeal filed beyond 120 days

  • Citation Number : LSI-713-SC-2019(NDEL)

HC: Refuses to pierce corporate veil for recovery of dues against non-signatory parties

  • Citation Number : LSI-712-HC-2019(ALLD)

SAT: Upholds penalty imposed by NSE on Stock broker misusing clients’ securities

  • Citation Number : LSI-711-SAT-2019(MUM)

SAT: Quashes SEBI order debarring Director from market, absent involvement in fraudulent GDR issue

  • Citation Number : LSI-710-SAT-2019(MUM)

NCLAT: Sets aside NCLT order approving amalgamation scheme based on unfair valuation report

  • Citation Number : LSI-708-NCLAT-2019(NDEL)

NCLAT: Stays NCLT order directing impleadment of MCA as party in all IBC cases

  • Citation Number : LSI-707-NCLAT-2019(NDEL)

NCLT: Allows Corporate Debtor to submit post-insolvency initiation GST returns before clearing past dues

  • Citation Number : LSI-703-NCLT-2019(CHE)

NCLAT: Dismisses appeal against NCLT order rejecting review application in respect of demerger scheme

  • Citation Number : LSI-701-NCLAT-2019(NDEL)

SEBI: Clarifies over investment conditions in LLP by Category II AIF

  • Citation Number : LSI-700- SEBI-2019(MUM)

NCLAT: NCLT cannot impose conditions regarding Corporate Debtor’s right to receivables or over subsidiaries

  • Citation Number : LSI-699-NCLAT-2019(NDEL)

SC: HC cannot proceed with auction of Corporate Debtor’s property once moratorium declared

  • Citation Number : LSI-694-SC-2019(NDEL)

NCLT: Upholds RP’s rejection of claim against Corporate Debtor considering its uncrystallised, unliquidated nature

  • Citation Number : LSI-693-NCLT-2019(MUM)

NCLAT: Sets aside resolution plan offering amount less than ‘liquidation value’ for Orchid Pharma

  • Citation Number : LSI-692-NCLAT-2019(NDEL)